Parvin Fardipour

Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development

Brenda Gaydos, Keaven M. Anderson, Donald A. Berry et al. · Drug Information Journal · 2009 · 115 citations

Adaptive Clinical Trials, Clinical Trial Management, Pharmacology +10

Impact of Dose Selection Strategies Used in Phase II on the Probability of Success in Phase III

Zoran Antonijevic, José Paulo Pinheiro, Parvin Fardipour et al. · Statistics in Biopharmaceutical Research · 2010 · 50 citations

Dose Selection Strategies, Radiation Exposure, Treatment Plan Evaluation +20

Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies

José Paulo Pinheiro, Frederic L. Sax, Zoran Antonijevic et al. · Statistics in Biopharmaceutical Research · 2010 · 43 citations

Model-based Dose-ranging Trials, White Paper, Pharmacotherapy +22

A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug

Scott Berry, Walter Spinelli, Gary S. Littman et al. · Clinical Trials · 2010 · 42 citations

Simulation Practices for Adaptive Trial Designs in Drug and Device Development

Cristiana Mayer, Inna Perevozskaya, Sergei Leonov et al. · Statistics in Biopharmaceutical Research · 2019 · 26 citations

Engineering, Clinical Endpoint, Optimal Experimental Design +21